VESANOID Side Effects

7014635-3 | Hepatic Function Abnormal
on Sep 17, 2010 Male patient from JAPAN , weighting 147.7 lb, was diagnosed with acute promyelocytic leukaemia, infection prophylaxis, prophylaxis against gastrointestinal ulcer, hyperuricaemia and was treated with Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal. Vesanoid dosage: . During the same period patient was treated with BAKTAR (Note: Dosage Is Uncertain) (View Baktar Review and Baktar Label ), POLYMYXIN B SULFATE (Dosage Is Uncertain) (View Polymyxin-b-sulfate Review and Polymyxin-b-sulfate Label ), FUNGIZONE (Dosage Is Uncertain) (View Fungizone Review and Fungizone Label ), HICALIQ (View Hicaliq Review and Hicaliq Label ), AMLODIPINE BESYLATE (Amlodin Od, Dosage Is Uncertain) (View Amlodipine Besylate Review and Amlodipine Besylate Label ), MEROPEN (Dosage Is Uncertain) (View Meropen Review and Meropen Label ), OMEPRAL (Dosage Is Uncertain) (View Omepral Review and Omepral Label ), ALOSITOL (View Alositol Review and Alositol Label ).

6958518-3 | Blood Alkaline Phosphatase Increased
Patient was taking Vesanoid (View Usage). Patient had the following side effects: blood alkaline phosphatase increased on Aug 20, 2010 from JAPAN Additional patient health information: Male patient , 63 years of age, was diagnosed with acute promyelocytic leukaemia and. Vesanoid dosage: . During the same period patient was treated with COTRIM (Dosage Is Uncertain. Dose Form: Peroral Agent) (View Cotrim Review and Cotrim Label ), POLYMYXIN B SULFATE (Dosage Is Uncertain.) (View Polymyxin-b-sulfate Review and Polymyxin-b-sulfate Label ), FUNGIZONE (Dosage Is Uncertain) (View Fungizone Review and Fungizone Label ), HICALIQ (View Hicaliq Review and Hicaliq Label ), AMLODIPINE BESYLATE (Dosage Is Uncertain) (View Amlodipine Besylate Review and Amlodipine Besylate Label ), REMINARON (Dosage Is Uncertain) (View Reminaron Review and Reminaron Label ), MEROPENEM (Dosage Is Uncertain) (View Meropenem Review and Meropenem Label ), OMEPRAL (Dosage Is Uncertain) (View Omepral Review and Omepral Label ).

6930311-7 | Cellulitis, Psychotic Disorder, Pyrexia, Sleep Terror
Adverse event was reported on Aug 10, 2010 by a Male patient taking Vesanoid (View Usage) (Dosage: ) was diagnosed with prophylaxis, infection (What is infection?) and. Location: UNITED STATES , weighting 12.35 lb, After Vesanoid was administered, patient had the following side effects: cellulitis (What is cellulitis?), psychotic disorder (What is psychotic disorder?), pyrexia, sleep terror. During the same period patient was treated with MICAFUNGIN (View Micafungin Review and Micafungin Label ), LINEZOLID (View Linezolid Review and Linezolid Label ), MEROPENEM (View Meropenem Review and Meropenem Label ).

6871149-9 | Acute Promyelocytic Leukaemia Differentiation Syndrome, Haemorrhage Intracranial, Histiocytosis Haematophagic, Pulmonary Alveolar Haemorrhage, Sepsis
on Jul 13, 2010 Female patient from JAPAN , weighting 94.80 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: acute promyelocytic leukaemia differentiation syndrome, haemorrhage intracranial, histiocytosis haematophagic, pulmonary alveolar haemorrhage, sepsis (What is sepsis?). Vesanoid dosage: 3 Times A Day (3 Caps After Breakfast, 2 After Lunch, 2 After Dinner.. During the same period patient was treated with VANCOMYCIN HYDROCHLORIDE (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ), CYLOCIDE (Route: Intravenous (not Otherwise Specified)) (View Cylocide Review and Cylocide Label ), IDAMYCIN (Route: Intravenous (not Otherwise Specified)) (View Idamycin Review and Idamycin Label ), ITRIZOLE (View Itrizole Review and Itrizole Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), BROACT (Route: Intravenous (not Otherwise Specified)) (View Broact Review and Broact Label ), HABEKACIN (Route: Intravenous (not Otherwise Specified)) (View Habekacin Review and Habekacin Label ), FUNGUARD (Route: Intravenous (not Otherwise Specified)) (View Funguard Review and Funguard Label ). Patient was hospitalized.


6871136-0 | Abnormal Behaviour, Asthma, Autism, Hypocalcaemia, Hypoglycaemia Neonatal, Neonatal Respiratory Distress Syndrome, Obesity, Premature Baby
on Jul 09, 2010 Female patient from UNITED KINGDOM , weighting 3.97 lb, was diagnosed with constipation (What is constipation?), pain (What is pain?) and was treated with Vesanoid (View Usage). Patient had the following side effects: abnormal behaviour, asthma (What is asthma?), autism (What is autism?), hypocalcaemia, hypoglycaemia neonatal, neonatal respiratory distress syndrome, obesity (What is obesity?), premature baby. Vesanoid dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN K TAB (View Vitamin K Tab Review and Vitamin K Tab Label ), SENNA (View Senna Review and Senna Label ), CO DYDRAMOL (View Co-dydramol Review and Co-dydramol Label ), ACETAMINOPHEN WITH PROPOXYPHENE HCL TAB (View Acetaminophen With Propoxyphene Hcl Tab Review and Acetaminophen With Propoxyphene Hcl Tab Label ), VOLTAREN (View Voltaren Review and Voltaren Label ). Patient was hospitalized.

6795193-5 | Cellulitis, Psychotic Disorder, Pyrexia, Sleep Terror
Patient was taking Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: cellulitis (What is cellulitis?), psychotic disorder (What is psychotic disorder?), pyrexia, sleep terror on Jun 17, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 12.35 lb, . Vesanoid dosage: .

6795089-9 | Acute Promyelocytic Leukaemia Differentiation Syndrome, Haemorrhage Intracranial, Histiocytosis Haematophagic, Pulmonary Alveolar Haemorrhage, Sepsis
Adverse event was reported on Jun 17, 2010 by a Female patient taking Vesanoid (View Usage) (Dosage: 3 Times A Day (3 Caps After Breakfast, 2 After Lunch, 2 After Dinner.) was diagnosed with acute promyelocytic leukaemia and. Location: JAPAN , weighting 94.80 lb, Patient experienced the following unwanted or unexpected effects: acute promyelocytic leukaemia differentiation syndrome, haemorrhage intracranial, histiocytosis haematophagic, pulmonary alveolar haemorrhage, sepsis (What is sepsis?). During the same period patient was treated with CYLOCIDE (Route: Intravenous (not Otherwise Specified)) (View Cylocide Review and Cylocide Label ), IDAMYCIN (Route: Intravenous (not Otherwise Specified)) (View Idamycin Review and Idamycin Label ), ITRIZOLE (View Itrizole Review and Itrizole Label ), PARIET (View Pariet Review and Pariet Label ), BROACT (Route: Intravenous (not Otherwise Specified)) (View Broact Review and Broact Label ), HABEKACIN (Route: Intravenous (not Otherwise Specified)) (View Habekacin Review and Habekacin Label ), FUNGUARD (Route: Intravenous (not Otherwise Specified)) (View Funguard Review and Funguard Label ), EXACIN (Route: Intravenous (not Otherwise Specified)) (View Exacin Review and Exacin Label ). Patient was hospitalized.

6781519-5 | Psychotic Disorder
on Jun 11, 2010 Male patient from UNITED STATES , weighting 12.35 lb, was treated with Vesanoid (View Usage). Patient had the following side effects: psychotic disorder (What is psychotic disorder?). Vesanoid dosage: .

6761419-7 | Acute Promyelocytic Leukaemia Differentiation Syndrome, Haemorrhage Intracranial, Histiocytosis Haematophagic, Pulmonary Alveolar Haemorrhage, Retinoic Acid Syndrome, Sepsis
on May 26, 2010 Female patient from JAPAN , weighting 94.80 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: acute promyelocytic leukaemia differentiation syndrome, haemorrhage intracranial, histiocytosis haematophagic, pulmonary alveolar haemorrhage, retinoic acid syndrome, sepsis (What is sepsis?). Vesanoid dosage: . During the same period patient was treated with CYLOCIDE (View Cylocide Review and Cylocide Label ), IDAMYCIN (View Idamycin Review and Idamycin Label ), ITRIZOLE (View Itrizole Review and Itrizole Label ), PARIET (View Pariet Review and Pariet Label ), BROACT (View Broact Review and Broact Label ), HABEKACIN (View Habekacin Review and Habekacin Label ), FUNGUARD (View Funguard Review and Funguard Label ), EXACIN (View Exacin Review and Exacin Label ). Patient was hospitalized.

6758413-9 | Haemorrhage Intracranial, Histiocytosis Haematophagic, Pulmonary Alveolar Haemorrhage, Retinoic Acid Syndrome, Sepsis
Patient was taking Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage intracranial, histiocytosis haematophagic, pulmonary alveolar haemorrhage, retinoic acid syndrome, sepsis (What is sepsis?) on Jun 04, 2010 from JAPAN Additional patient health information: Female patient , 17 years of age, was diagnosed with acute promyelocytic leukaemia and. Vesanoid dosage: Note: Dosage Is Uncertain.. During the same period patient was treated with IDAMYCIN (Note: Dosage Is Uncertain.) (View Idamycin Review and Idamycin Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), VANCOMYCIN HYDROCHLORIDE (Note: Dosage Is Uncertain.) (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ).

6751533-4 | Haemorrhage Intracranial, Histiocytosis Haematophagic, Pulmonary Alveolar Haemorrhage, Retinoic Acid Syndrome, Sepsis
Adverse event was reported on May 19, 2010 by a Female patient taking Vesanoid (View Usage) (Dosage: Note: Dosage Is Uncertain.) was diagnosed with acute promyelocytic leukaemia and. Location: JAPAN , 17 years of age, Patient had the following side effects: haemorrhage intracranial, histiocytosis haematophagic, pulmonary alveolar haemorrhage, retinoic acid syndrome, sepsis (What is sepsis?). During the same period patient was treated with IDAMYCIN (Note: Dosage Is Uncertain.) (View Idamycin Review and Idamycin Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), VANCOMYCIN HYDROCHLORIDE (Note: Dosage Is Uncertain.) (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ).

6751454-7 | Diarrhoea, Overdose, Suicide Attempt
on May 24, 2010 Male patient from UNITED STATES , 31 years of age, was treated with Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: diarrhoea, overdose, suicide attempt. Vesanoid dosage: Formulation: Pills, Dosage Regimen: 100 Pills Of 10 Mg Tretinoin. During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ), VIOGEN C (View Viogen-c Review and Viogen-c Label ), TRICOR (View Tricor Review and Tricor Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ANDROGEL (View Androgel Review and Androgel Label ). Patient was hospitalized.

6738001-0 | Ascites, Blood Bilirubin Increased, Septic Shock, Transaminases Increased
on May 17, 2010 Male patient from JAPAN , 77 years of age, was treated with Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, blood bilirubin increased, septic shock, transaminases increased. Vesanoid dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6724104-3 | Acute Promyelocytic Leukaemia, Endotracheal Intubation
Patient was taking Vesanoid (View Usage). Patient had the following side effects: acute promyelocytic leukaemia, endotracheal intubation on Apr 23, 2010 from UNITED STATES Additional patient health information: Female patient , 73 years of age, was diagnosed with acute promyelocytic leukaemia and. Vesanoid dosage: . Patient was hospitalized.

6719510-7 | Acute Promyelocytic Leukaemia, Endotracheal Intubation
Adverse event was reported on Apr 23, 2010 by a Female patient taking Vesanoid (View Usage) (Dosage: ) was diagnosed with acute promyelocytic leukaemia and. Location: UNITED STATES , 73 years of age, After Vesanoid was administered, patient had the following side effects: acute promyelocytic leukaemia, endotracheal intubation. Patient was hospitalized.

6686523-3 | Uterine Contractions Abnormal
on Apr 07, 2010 Female patient from JAPAN , 31 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: uterine contractions abnormal. Vesanoid dosage: Note: Dosage Is Uncertain..

6676831-4 | Acute Promyelocytic Leukaemia Differentiation Syndrome, Histiocytosis Haematophagic
on Apr 02, 2010 Female patient from JAPAN , weighting 94.80 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). Patient had the following side effects: acute promyelocytic leukaemia differentiation syndrome, histiocytosis haematophagic. Vesanoid dosage: . During the same period patient was treated with CYLOCIDE (View Cylocide Review and Cylocide Label ), IDAMYCIN (View Idamycin Review and Idamycin Label ), ITRIZOLE (View Itrizole Review and Itrizole Label ), PARIET (View Pariet Review and Pariet Label ), BROACT (View Broact Review and Broact Label ), HABEKACIN (View Habekacin Review and Habekacin Label ), FUNGUARD (View Funguard Review and Funguard Label ), EXACIN (View Exacin Review and Exacin Label ). Patient was hospitalized.

6653308-3 | Neutropenia, Sepsis, Thrombocytopenia
Patient was taking Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: neutropenia, sepsis (What is sepsis?), thrombocytopenia on Mar 17, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 143.1 lb, . Vesanoid dosage: Dose: 2x10 Mg Capsules X 10 Days, Bid. During the same period patient was treated with MERCAPTOPURINE (View Mercaptopurine Review and Mercaptopurine Label ), METHOTREXATE (Dose: 12.5 Mg Weekly) (View Methotrexate Review and Methotrexate Label ).

6648278-8 | Pyrexia, Retinoic Acid Syndrome, Septic Shock
Adverse event was reported on Mar 17, 2010 by a Male patient taking Vesanoid (View Usage) (Dosage: ) was diagnosed with acute promyelocytic leukaemia and. Location: JAPAN , weighting 130.1 lb, Patient experienced the following unwanted or unexpected effects: pyrexia, retinoic acid syndrome, septic shock. During the same period patient was treated with FARMORUBICIN (View Farmorubicin Review and Farmorubicin Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), NEO MINOPHAGEN C (View Neo-minophagen C Review and Neo-minophagen C Label ), LANSOPRAZOLE (Form: Peroral Agent) (View Lansoprazole Review and Lansoprazole Label ), LASIX (Form: Peroral Agent) (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), MYSLEE (View Myslee Review and Myslee Label ). Patient was hospitalized.

6644441-0 | Cardiac Failure, Lip Dry, Lip Ulceration, Pharyngitis
on Mar 10, 2010 Female patient from JAPAN , 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). Patient had the following side effects: cardiac failure, lip dry, lip ulceration, pharyngitis. Vesanoid dosage: . During the same period patient was treated with IDARUBICIN HYDROCHLORIDE (View Idarubicin Hydrochloride Review and Idarubicin Hydrochloride Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ).

6599518-5 | Pyrexia, Retinoic Acid Syndrome, Septic Shock
on Feb 12, 2010 Male patient from JAPAN , weighting 130.1 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: pyrexia, retinoic acid syndrome, septic shock. Vesanoid dosage: . During the same period patient was treated with FARMORUBICIN (View Farmorubicin Review and Farmorubicin Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), NEO MINOPHAGEN C (View Neo-minophagen C Review and Neo-minophagen C Label ), TAKEPRON (Form: Peroral Agent) (View Takepron Review and Takepron Label ), LASIX (Form: Peroral Agent) (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), MYSLEE (View Myslee Review and Myslee Label ). Patient was hospitalized.

6571924-4 | Coagulopathy, Respiratory Failure
Patient was taking Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: coagulopathy, respiratory failure on Jan 26, 2010 from BRAZIL Additional patient health information: Female patient , 32 years of age, weighting 143.3 lb, . Vesanoid dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

6546524-2 | Atrial Fibrillation, Tachycardia, Ventricular Arrhythmia
Adverse event was reported on Dec 16, 2008 by a Female patient taking Vesanoid (View Usage) (Dosage: ) . Location: UNITED STATES , 70 years of age, Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), tachycardia, ventricular arrhythmia. Patient was hospitalized.

6544475-0 | Gastrointestinal Toxicity, Hepatotoxicity
on Jan 11, 2010 Female patient from SPAIN , 33 years of age, was treated with Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: gastrointestinal toxicity, hepatotoxicity. Vesanoid dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), AMIKACIN SULFATE (View Amikacin Sulfate Review and Amikacin Sulfate Label ), AMOXICILLIN SODIUM (View Amoxicillin Sodium Review and Amoxicillin Sodium Label ), AMBISOME (View Ambisome Review and Ambisome Label ), CEFEPIME (View Cefepime Review and Cefepime Label ), CHLORHEXIDINE GLUCONATE (View Chlorhexidine Gluconate Review and Chlorhexidine Gluconate Label ), CODEINE (View Codeine Review and Codeine Label ), COLISTIN (View Colistin Review and Colistin Label ).

6530128-1 | Disease Progression
on Dec 16, 2009 Male patient from JAPAN , 63 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression. Vesanoid dosage: . During the same period patient was treated with DAUNORUBICIN HYDROCHLORIDE (View Daunorubicin Hydrochloride Review and Daunorubicin Hydrochloride Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ).

6523388-4 | Ascites, Sepsis
Patient was taking Vesanoid (View Usage). Patient had the following side effects: ascites, sepsis (What is sepsis?) on Dec 22, 2009 from JAPAN Additional patient health information: Male patient , 77 years of age, was diagnosed with acute promyelocytic leukaemia and. Vesanoid dosage: .

6515315-0 | Acute Myeloid Leukaemia
Adverse event was reported on Dec 17, 2009 by a Female patient taking Vesanoid (View Usage) (Dosage: ) was diagnosed with acute myeloid leukaemia and. Location: JAPAN , 55 years of age, After Vesanoid was administered, patient had the following side effects: acute myeloid leukaemia. During the same period patient was treated with ENOCITABINE (View Enocitabine Review and Enocitabine Label ).

6509607-9 | Gastrointestinal Toxicity, Hepatotoxicity
on Dec 14, 2009 Female patient from SPAIN , 33 years of age, was treated with Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal toxicity, hepatotoxicity. Vesanoid dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), CEFEPIME (View Cefepime Review and Cefepime Label ), CHLORHEXIDINE GLUCONATE (View Chlorhexidine Gluconate Review and Chlorhexidine Gluconate Label ), CODEINE (View Codeine Review and Codeine Label ), COLISTIN (View Colistin Review and Colistin Label ).

6460426-1 | Acute Myeloid Leukaemia
on Nov 16, 2009 Female patient from JAPAN , 55 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vesanoid (View Usage). Patient had the following side effects: acute myeloid leukaemia. Vesanoid dosage: . During the same period patient was treated with ENOCITABINE (Route: Injectable (not Otherwise Specified)) (View Enocitabine Review and Enocitabine Label ).

6436160-0 | Bradycardia, Dyspnoea, Electrocardiogram Abnormal, Hypoxia
Patient was taking Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: bradycardia, dyspnoea, electrocardiogram abnormal, hypoxia on Oct 30, 2009 from CANADA Additional patient health information: Female patient , 20 years of age, weighting 205.0 lb, . Vesanoid dosage: . During the same period patient was treated with CERUBIDINE (View Cerubidine Review and Cerubidine Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ZOFRAN (View Zofran Review and Zofran Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), PAROXETINE (View Paroxetine Review and Paroxetine Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ).

6417582-0 | Acute Myeloid Leukaemia
Adverse event was reported on Oct 14, 2009 by a Female patient taking Vesanoid (View Usage) (Dosage: ) was diagnosed with acute myeloid leukaemia and. Location: JAPAN , 55 years of age, Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia. During the same period patient was treated with ENOCITABINE (Route: Injectable (not Otherwise Specified)) (View Enocitabine Review and Enocitabine Label ).

6417576-5 | Disease Progression, Retinoic Acid Syndrome
on Oct 14, 2009 Female patient from JAPAN , 68 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). Patient had the following side effects: disease progression, retinoic acid syndrome. Vesanoid dosage: .

6312317-4 | Diarrhoea, Haemoglobin Decreased, Suicide Attempt
on Aug 03, 2009 Male patient from SINGAPORE , 31 years of age, was treated with Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: diarrhoea, haemoglobin decreased, suicide attempt. Vesanoid dosage: Formulation: Pills. Patient Ingested 100 Pills.. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), EPIVIR (View Epivir Review and Epivir Label ), VIOGEN C (Druig: Viogen: Vitamin B Complex With C And Minerals) (View Viogen-c Review and Viogen-c Label ), TRICOR (View Tricor Review and Tricor Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ANDROGEL (View Androgel Review and Androgel Label ). Patient was hospitalized.

6170001-4 | Wernicke's Encephalopathy
Patient was taking Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: wernicke's encephalopathy on Apr 15, 2009 from JAPAN Additional patient health information: Male patient , 26 years of age, . Vesanoid dosage: .

6145924-2 | Aortitis
Adverse event was reported on Mar 24, 2009 by a Female patient taking Vesanoid (View Usage) (Dosage: ) . Location: JAPAN , 60 years of age, Patient had the following side effects: aortitis.

6082309-1 | Blood Triglycerides Increased, Pulmonary Oedema, Respiratory Distress
on Oct 01, 2008 Female patient from UNITED STATES , 62 years of age, was treated with Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: blood triglycerides increased, pulmonary oedema, respiratory distress. Vesanoid dosage: .

6082289-9 | Papilloedema
on Jun 23, 2008 Male patient from UNITED STATES , 24 years of age, was treated with Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: papilloedema. Vesanoid dosage: .

6082288-7 | Benign Intracranial Hypertension, Headache
Patient was taking Vesanoid (View Usage). Patient had the following side effects: benign intracranial hypertension, headache (What is headache?) on Jun 16, 2008 from UNITED STATES Additional patient health information: Male patient , 16 years of age, weighting 286.6 lb, was diagnosed with acute promyelocytic leukaemia and. Vesanoid dosage: 30 Mg 2 Per Day Oral. During the same period patient was treated with LORATADINE (View Loratadine Review and Loratadine Label ), DOCUSATE (DOCUSATE SODIUM) (View Docusate (docusate Sodium) Review and Docusate (docusate Sodium) Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), TOPIRAMATE (View Topiramate Review and Topiramate Label ).

6082267-X | Lung Infiltration, Respiratory Distress
Adverse event was reported on Feb 14, 2008 by a Male patient taking Vesanoid (View Usage) (Dosage: ) . Location: UNITED STATES , 68 years of age, After Vesanoid was administered, patient had the following side effects: lung infiltration, respiratory distress. During the same period patient was treated with EPIRUBICIN (View Epirubicin Review and Epirubicin Label ).

6045747-9 | Myelodysplastic Syndrome
on Jan 15, 2009 Female patient from JAPAN , 51 years of age, weighting 81.57 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: myelodysplastic syndrome. Vesanoid dosage: . During the same period patient was treated with IDAMYCIN (68 Mg In Total) (View Idamycin Review and Idamycin Label ), NOVANTRONE (View Novantrone Review and Novantrone Label ), ADRIACIN (204 Mg In Total) (View Adriacin Review and Adriacin Label ), CYLOCIDE (700mg In Total) (View Cylocide Review and Cylocide Label ).

6020432-8 | Arthralgia, Myalgia
on Dec 15, 2008 Male patient from JAPAN , 60 years of age, was treated with Vesanoid (View Usage). Patient had the following side effects: arthralgia, myalgia. Vesanoid dosage: .

6011425-5 | Interstitial Lung Disease, Mediastinal Haematoma, Retinoic Acid Syndrome
Patient was taking Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: interstitial lung disease, mediastinal haematoma, retinoic acid syndrome on Mar 30, 2000 from JAPAN Additional patient health information: Female patient , 61 years of age, was diagnosed with acute myeloid leukaemia and. Vesanoid dosage: .

5988583-1 | Purpura
Adverse event was reported on Dec 02, 2008 by a Female patient taking Vesanoid (View Usage) (Dosage: ) was diagnosed with prophylaxis, acute promyelocytic leukaemia, hypertension and. Location: UNITED STATES , 38 years of age, weighting 131.0 lb, Patient experienced the following unwanted or unexpected effects: purpura. During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), CEFTAZIDIME (Taken Every 8 Hours.) (View Ceftazidime Review and Ceftazidime Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), IDANTOIN (View Idantoin Review and Idantoin Label ), VANCOMYCIN (Taken Every 12 Hours.) (View Vancomycin Review and Vancomycin Label ), METOPROLOL TARTRATE (Route: Iv/oral, Strength: 5 Mg/25 Mg. Taken Once.) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), FUROSEMIDE (Taken Daily.) (View Furosemide Review and Furosemide Label ).

5987117-5 | Aortitis
on Nov 28, 2008 Female patient from JAPAN , 60 years of age, was treated with Vesanoid (View Usage). Patient had the following side effects: aortitis. Vesanoid dosage: .

5961319-6 | Myelodysplastic Syndrome
on Nov 13, 2008 Female patient from JAPAN , 51 years of age, weighting 81.57 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: myelodysplastic syndrome. Vesanoid dosage: . During the same period patient was treated with IDAMYCIN (68 Mg In Total) (View Idamycin Review and Idamycin Label ), NOVANTRONE (View Novantrone Review and Novantrone Label ), ADRIACIN (204 Mg In Total) (View Adriacin Review and Adriacin Label ), CYLOCIDE (700mg In Total) (View Cylocide Review and Cylocide Label ).

5958485-5 | Aspiration, Malaise
Patient was taking Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: aspiration, malaise on Nov 12, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 42 years of age, . Vesanoid dosage: .

5953492-0 | Altered State Of Consciousness, Delirium
Adverse event was reported on Nov 05, 2008 by a Male patient taking Vesanoid (View Usage) (Dosage: ) was diagnosed with acute promyelocytic leukaemia and. Location: JAPAN , 52 years of age, Patient had the following side effects: altered state of consciousness, delirium.

5946620-4 | Arthralgia, Myalgia
on Oct 31, 2008 Male patient from JAPAN , 60 years of age, was treated with Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: arthralgia, myalgia. Vesanoid dosage: .

5940363-9 | Altered State Of Consciousness, Delirium
on Oct 24, 2008 Male patient from JAPAN , 52 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, delirium. Vesanoid dosage: .

5938711-9 | Neutropenic Sepsis, Retinoic Acid Syndrome
Patient was taking Vesanoid (View Usage). Patient had the following side effects: neutropenic sepsis, retinoic acid syndrome on Oct 20, 2008 from GERMANY Additional patient health information: Female patient , 23 years of age, weighting 110.2 lb, was diagnosed with acute promyelocytic leukaemia and. Vesanoid dosage: .